Reduction of serum testosterone levels during chronic glucocorticoid therapy

Ann Intern Med. 1986 May;104(5):648-51. doi: 10.7326/0003-4819-104-5-648.

Abstract

The effect of chronic glucocorticoid therapy on serum testosterone levels was studied in men aged 67 +/- 4 (SD) years with chronic pulmonary disease. The serum testosterone level was reduced in 14 of 16 patients to a mean value of 211 +/- 93 ng/dL, compared with 449 +/- 111 ng/dL in 11 age- and disease-matched control patients (p less than 0.001). The corticosteroid dosage and the serum testosterone level were inversely related (r = -0.78). Testosterone binding to serum proteins was not significantly affected. Basal gonadotrophin levels were not elevated while their secretory responses to exogenous gonadotrophin-releasing hormone (GnRH) were intact. We conclude that glucocorticoid therapy commonly reduces serum testosterone levels in older men due to alteration of hypothalamic GnRH secretion.

MeSH terms

  • Aged
  • Follicle Stimulating Hormone / blood
  • Glucocorticoids / adverse effects*
  • Gonadotropin-Releasing Hormone / metabolism
  • Humans
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism
  • Lung Diseases, Obstructive / drug therapy
  • Luteinizing Hormone / blood
  • Male
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / adverse effects
  • Middle Aged
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Testosterone / blood*
  • Time Factors

Substances

  • Glucocorticoids
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Prednisone
  • Methylprednisolone